Compare Abbott India with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs J.B.CHEMICALS - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA J.B.CHEMICALS ABBOTT INDIA/
J.B.CHEMICALS
 
P/E (TTM) x 53.0 45.5 116.5% View Chart
P/BV x 17.1 8.5 202.5% View Chart
Dividend Yield % 0.4 0.1 288.6%  

Financials

 ABBOTT INDIA   J.B.CHEMICALS
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
J.B.CHEMICALS
Mar-18
ABBOTT INDIA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs8,834363 2,433.0%   
Low Rs5,458255 2,140.2%   
Sales per share (Unadj.) Rs1,731.1169.1 1,023.5%  
Earnings per share (Unadj.) Rs211.916.6 1,276.7%  
Cash flow per share (Unadj.) Rs219.923.4 939.0%  
Dividends per share (Unadj.) Rs65.002.00 3,250.0%  
Dividend yield (eoy) %0.90.6 140.6%  
Book value per share (Unadj.) Rs945.2172.5 548.0%  
Shares outstanding (eoy) m21.2583.57 25.4%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.11.8 225.9%   
Avg P/E ratio x33.718.6 181.1%  
P/CF ratio (eoy) x32.513.2 246.2%  
Price / Book Value ratio x7.61.8 422.0%  
Dividend payout %30.712.0 254.6%   
Avg Mkt Cap Rs m151,84825,827 587.9%   
No. of employees `0003.53.8 92.4%   
Total wages/salary Rs m4,3562,511 173.5%   
Avg. sales/employee Rs Th10,555.53,747.4 281.7%   
Avg. wages/employee Rs Th1,249.9665.7 187.8%   
Avg. net profit/employee Rs Th1,292.2367.8 351.4%   
INCOME DATA
Net Sales Rs m36,78614,135 260.2%  
Other income Rs m1,133366 309.7%   
Total revenues Rs m37,91914,501 261.5%   
Gross profit Rs m6,0472,178 277.6%  
Depreciation Rs m169570 29.7%   
Interest Rs m2335 64.5%   
Profit before tax Rs m6,9891,940 360.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,485552 450.0%   
Profit after tax Rs m4,5031,387 324.6%  
Gross profit margin %16.415.4 106.7%  
Effective tax rate %35.628.5 124.9%   
Net profit margin %12.29.8 124.7%  
BALANCE SHEET DATA
Current assets Rs m27,61010,470 263.7%   
Current liabilities Rs m8,5692,749 311.7%   
Net working cap to sales %51.854.6 94.8%  
Current ratio x3.23.8 84.6%  
Inventory Days Days6055 109.1%  
Debtors Days Days2778 35.3%  
Net fixed assets Rs m1,0575,811 18.2%   
Share capital Rs m213167 127.2%   
"Free" reserves Rs m19,87314,248 139.5%   
Net worth Rs m20,08614,416 139.3%   
Long term debt Rs m00-   
Total assets Rs m29,40917,649 166.6%  
Interest coverage x311.656.6 550.8%   
Debt to equity ratio x00-  
Sales to assets ratio x1.30.8 156.2%   
Return on assets %15.48.1 191.0%  
Return on equity %22.49.6 233.0%  
Return on capital %34.913.7 254.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3696,164 6.0%   
Fx outflow Rs m4,9181,334 368.6%   
Net fx Rs m-4,5494,829 -94.2%   
CASH FLOW
From Operations Rs m4,9911,231 405.6%  
From Investments Rs m-2,570-208 1,235.0%  
From Financial Activity Rs m-1,428-595 239.9%  
Net Cashflow Rs m993427 232.6%  

Share Holding

Indian Promoters % 0.0 55.4 -  
Foreign collaborators % 75.0 0.3 25,000.0%  
Indian inst/Mut Fund % 7.9 3.4 233.0%  
FIIs % 0.1 3.9 2.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 37.0 46.2%  
Shareholders   18,270 30,437 60.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   ORCHID PHARMA  WYETH  TORRENT PHARMA  SUVEN LIFE SCIENCES  CIPLA  

Compare ABBOTT INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Snap 4-Day Winning Streak; JSW Steel and Hindalco Among Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


May 11, 2021 03:36 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS